-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In the general population, women have a lower
This study compared cardiometabolic risk factor profiles, cardiac protection drug use, and CVD events in men and women with type 1 diabetes and followed up for approximately 29 years in the Diabetes Control and Complications Trial/Diabetes Intervention and Complication Epidemiology (DCCT/EDIC) study
Results Showed that a total of 1441 patients with type 1 diabetes mellitus (mean [SD] age at DCCT baseline, 26.
Women reached the recommended blood pressure (i.
During dcct/EDIC, 113 women (16.
Guidelines for treatment to waist circumference, blood pressure, lipids, and HbA1c reduced the risk of any CVD by 30% to 57%, while meeting lipid targets was associated
These findings suggest that although cardiometabolic risk factor profiles are more favorable, the burden of CVD events in women with type 1 diabetes is not significantly lower than in men, suggesting that the clinical impact of cardiometabolic risk factors is greater
Original source:
Braffett BH, Bebu I, El ghormli L, et al.